×

- Yhim HY, Jang MJ, Kwak JY, Yim CY, Choi WI, Lee YC, Lee JO, Lee KW, Bang
SM, Kim SH, Kim YK, Chang HJ, Oh D, Korean Venous Thromboembolism
Working P. The incidence, risk factors, and prognosis of recurrent
venous thromboembolism (VTE) in patients with advanced solid cancers
receiving anticoagulation therapy after the diagnosis of index VTE.
Thromb Res 2013; 131: e133-40.

- Lee SE, Choi SY, Bang JH, Kim SH, Jang EJ, Byeun JY, Park JE, Jeon HR,
Oh YJ, Kim HJ, Kim YK, Park JS, Jeong SH, Kim SH, Zang DY, Oh S, Koo
DH, Kim H, Do YR, Kwak JY, Kim JA, Kim DY, Mun YC, Mauro MJ, Kim DW.
Predictive factors for successful imatinib cessation in chronic
myeloid leukemia patients treated with imatinib. Am J Hematol 2013.

- Yhim HY, Lee NR, Song EK, Yim CY, Jeon SY, Shin S, Kim JA, Kim HS, Cho
EH, Kwak JY. Imatinib mesylate discontinuation in patients with
chronic myeloid leukemia who have received front-line imatinib
mesylate therapy and achieved complete molecular response. Leuk Res
2012.

- Yhim HY, Kim HS, Lee NR, Song EK, Kwak JY, Yim CY. Bilateral subdural
hemorrhage as a serious adverse event of dasatinib in a patient with
Philadelphia chromosome-positive acute lymphoblastic leukemia. Int J
Hematol 2012.

- Kwak JY. Treatment of diffuse large B cell lymphoma. Korean J Intern Med
2012; 27: 369-77.
- Kim SJ, Moon JH, Kim H, Kim JS, Hwang YY, Intragumtornchai T,
Issaragrisil S, Kwak JY, Lee JJ, Won JH, Reksodiputro AH, Lim ST,
Cheng AL, Kim WS, Kwong YL. Non-bacterial infections in Asian patients
treated with alemtuzumab: a retrospective study of the Asian Lymphoma
Study Group. Leuk Lymphoma 2012.

- Kim H, Lee KH, Yoon SS, Sohn SK, Joo YD, Kim SH, Kim BS, Choi JH, Kwak
JY, Hyun MS, Bae SH, Shin HJ, Won JH, Oh S, Lee WS, Park JH, Jung CW.
Allogeneic Hematopoietic Stem Cell Transplant for Adults over 40 Years
Old with Acquired Aplastic Anemia. Biol Blood Marrow Transplant 2012.

- Yhim HY, Kwon DH, Lee NR, Song EK, Yim CY, Kwak JY. Linear IgA bullous
dermatosis following autologous PBSC transplantation in a patient with
non-Hodgkins lymphoma. Bone Marrow Transplant 2011; 46: 156-8.

- Yhim HY, Kim JS, Kang HJ, Kim SJ, Kim WS, Choi CW, Eom HS, Kim JA, Lee
JH, Won JH, Shim H, Huh J, Lee DH, Suh C, Kwak JY. Matched-pair
analysis comparing the outcomes of primary breast and nodal diffuse
large B-cell lymphoma in patients treated with rituximab plus
chemotherapy. Int J Cancer 2011.

- Lee AS, Kim DH, Lee JE, Jung YJ, Kang KP, Lee S, Park SK, Kwak JY, Lee
SY, Lim ST, Sung MJ, Yoon SR, Kim W. Erythropoietin induces lymph node
lymphangiogenesis and lymph node tumor metastasis. Cancer Res 2011; 71:
4506-17.

- Kim SJ, Kang HJ, Kim JS, Oh SY, Choi CW, Lee SI, Won JH, Kim MK, Kwon
JH, Mun YC, Kwak JY, Kwon JM, Hwang IG, Kim HJ, Park J, Oh S, Huh J, Ko
YH, Suh C, Kim WS. Comparison of treatment strategies for patients with
intestinal diffuse large B-cell lymphoma: surgical resection followed
by chemotherapy versus chemotherapy alone. Blood 2011; 117: 1958-65.

- Kim SJ, Choi CW, Mun YC, Oh SY, Kang HJ, Lee SI, Won JH, Kim MK, Kwon
JH, Kim JS, Kwak JY, Kwon JM, Hwang IG, Kim HJ, Lee JH, Oh S, Park KW,
Suh C, Kim WS. Multicenter retrospective analysis of 581 patients with
primary intestinal non-hodgkin lymphoma from the Consortium for
Improving Survival of Lymphoma (CISL). BMC Cancer 2011; 11: 321.

- Yhim HY, Kang HJ, Choi YH, Kim SJ, Kim WS, Chae YS, Kim JS, Choi CW, Oh
SY, Eom HS, Kim JA, Lee JH, Won JH, Shim H, Lee JJ, Sung HJ, Kim HJ,
Lee DH, Suh C, Kwak JY. Clinical outcomes and prognostic factors in
patients with breast diffuse large B cell lymphoma; Consortium for
Improving Survival of Lymphoma (CISL) study. BMC Cancer 2010; 10: 321.